In 2025, FemTech startups secured significant funding, showing rapid growth and innovation in women's health solutions across diverse sectors.
FemTech, short for female technology, has emerged from a niche market focused on women's health into a substantial industry valued at approximately $9.12 billion in 2025, as per Fortune Business Insights. This sector's evolution reflects a growing recognition of the need for health solutions tailored specifically for women. Indeed, research firm Dealroom indicates that there are currently nine femtech unicorns worldwide, particularly thriving in North America and the EMEA regions.
Defining FemTech
The term FemTech, coined by Clue founder Ida Tin, encompasses a wide range of technology-driven products, services, and applications aimed specifically at enhancing women's health. This broad category includes solutions related to menstrual health, fertility, menopause, pregnancy, and sexual wellness, among others. As FemTech continues to mature, its influence is pulling major tech players to invest in and develop new tools aimed at improving women's health.
Key Players and Funding Rounds in 2025
2025 witnessed notable funding rounds across various FemTech startups, highlighting the potential for significant advancements in women's health. Here’s a closer look at some of the largest funding rounds from the year:
Oura: $900 million (October)
Oura, although not strictly a FemTech company, has made waves with its technology that assists in measuring basal body temperature and monitoring menstruation. In October 2025, Oura raised over $900 million in a Series E funding round, elevating its valuation to $11 billion. The funding was led by Fidelity Management & Research Company, catalyzing further development of its innovative health tracking solutions.
Tubulis: €344 million (October)
German biotech company Tubulis secured €344 million in October 2025 to advance its research on antibody drugs targeting ovarian cancer and lung adenocarcinomas. While Tubulis operates beyond the FemTech space, its contributions could significantly alter outcomes for women's health, particularly concerning cancers affecting women.
Future Family: $400 million (April)
Future Family is tackling the financial hurdles associated with fertility treatments. The company received $400 million in financing in April 2025, led by Clear Haven Capital Management. This capital allows Future Family to offer low-interest loans for expensive procedures like IVF and egg freezing, coupled with support resources for couples navigating these challenges.
Hims & Hers: $1 billion (June)
Hims & Hers raised $1 billion through debt financing in June 2025. This telehealth platform emphasizes personalized wellbeing solutions, with a specific focus on women's health through its Hers brand, covering areas such as skincare, birth control, and sexual health. The funds will support its international growth and expansion of AI-driven offerings.
Conceivable Life Sciences: $50 million (September)
With a mission to enhance IVF effectiveness, Conceivable Life Sciences raised $50 million in September 2025 during its Series A funding round. The startup employs AI and robotics in its IVF processes through its platform, Aura, aiming to mitigate human error and improve success rates for couples looking to conceive.
Mercy BioAnalytics: $59 million (September)
Also in September, Mercy BioAnalytics secured $59 million in Series B funding to advance its early cancer detection tests focusing on blood-based diagnostics for ovarian and lung cancers. Given the challenges in early diagnosis of ovarian cancer, their research could prove transformative in improving patient outcomes.
Visby Medical: $55 million (June)
Visby Medical aimed to empower women with its FDA-approved at-home STI test, raising $55 million in financing in June 2025. This development is significant, providing women with access to reliable testing in the privacy of their homes, thus removing barriers to essential health screenings.
Diana Health: $55 million (September)
Finally, Diana Health, which offers personalized care through a network of women’s health practices, announced a $55 million funding round in September 2025. The funding will facilitate their expansion into newly established health programs that focus on labor and women's health clinics, enhancing their clinical partnerships and online offerings.
The flourishing landscape of FemTech funding in 2025 signals a broader recognition of the importance of women's health innovations. As these companies continue to develop products and services tailored to women's needs, they pave the way for accessible, reliable health solutions.
